Sort
51,593 grants matching “hepatitis”
METHADONE AND HIV DRUG INTERACTIONS
$561,637Evan D Kharasch · Washington University · R01 · FY2012 · DA
Toxicological importance of CYP3A4 catalysis and inhibition
$561,595Irina F. Sevrioukova · University Of California-Irvine · R01 · FY2023 · ES
Toxicological importance of CYP3A4 catalysis and inhibition
$561,595Irina F. Sevrioukova · University Of California-Irvine · R01 · FY2022 · ES
Toxicological importance of CYP3A4 catalysis and inhibition
$561,595Irina F. Sevrioukova · University Of California-Irvine · R01 · FY2024 · ES
Hepadnavirus Infections and Liver Cancer
$561,568William Mason · Research Inst Of Fox Chase Can Ctr · R01 · FY2009 · AI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults
$561,369Tobias Gerhard · Rutgers, The State Univ Of N.J. · R01 · FY2020 · AG
Pathogenesis of Liver Fluke Induced Cancer in Thailand
$561,359Tulane University Of Louisiana · U01 · FY2005 · AI
Metabolic Actions of FGF21
$561,317Eleftheria Maratos-Flier · Beth Israel Deaconess Medical Center · R01 · FY2012 · DK
Metabolic Actions of FGF21
$561,317Eleftheria Maratos-Flier · Beth Israel Deaconess Medical Center · R01 · FY2014 · DK
A Mass Spectrometry System for Quantitative Proteomics
$561,294Peter Lobel · Rbhs-Robert Wood Johnson Medical School · S10 · FY2014 · OD
REGULATION OF HEPATIC AND PERIPHERAL GLUCOSE METABOLISM
$561,280University Of Texas Hlth Sci Ctr San Ant · R01 · FY2003 · DK
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis
$561,154Arun J Sanyal · Virginia Commonwealth University · R01 · FY2024 · DK
Quantitation of Factors Regulating Glucose Tolerance
$561,119Marilyn Ader · Cedars-Sinai Medical Center · R01 · FY2024 · DK
Structure and function of the HCV RNA replicase
$561,080Charles M. Rice · Rockefeller University · R01 · FY2009 · CA
Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease
$560,998Rolf F Kletzien · Metabolic Solutions Development Co · R42 · FY2012 · AA
Genetic and Metabolic Basis of Familial Lipodystrophies
$560,975Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2016 · DK
Driving lymphoid potential in multipotent hematopoietic progenitors by linker histones
$560,828Shangqin Guo · Yale University · R56 · FY2024 · HL
Disturbed Crosstalk between Cholesterol Homeostasis and Inflammation Resolution in NASH
$560,775Bishuang Cai · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK
Integrated Detection and Classification of Sepsis via Tensor Methods Using EHR
$560,749Anru Zhang · Duke University · R01 · FY2025 · HL
Increasing HCV Knowledge &Service Use in Drug Tx Pgms
$560,740National Development &Res Institutes · R01 · FY2004 · DA
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
$560,735David B Agus · University Of Southern California · R01 · FY2016 · CA
Genetic and Metabolic Basis of Familial Lipodystrophies
$560,704Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2015 · DK
Exploratory Research on Late Initiation of Drug Injection
$560,652Ricky N Bluthenthal · University Of Southern California · R01 · FY2011 · DA
Treatment Study Using Depot Naltrexone(1/6)Philadelphia Coord/Data Mgmt Site
$560,640Charles P O'Brien · University Of Pennsylvania · R01 · FY2012 · DA
Developmental pathways, environmental agents, and epigenetics in liver disease
$560,612Keith D Robertson · Mayo Clinic Rochester · R01 · FY2013 · AA